Jason Hampson
General Counsel chez KINNATE BIOPHARMA INC.
Profil
Jason Hampson is currently the Vice President & Head-Regulatory Affairs at Kinnate Biopharma, Inc. He previously worked as the Director-Regulatory Affairs at Amgen, Inc. Hampson completed his undergraduate degree at the University of the West of England.
Postes actifs de Jason Hampson
| Sociétés | Poste | Début |
|---|---|---|
| KINNATE BIOPHARMA INC. | General Counsel | 07/06/2021 |
Anciens postes connus de Jason Hampson
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | General Counsel | 01/05/2021 |
Formation de Jason Hampson
| University of the West of England | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
